Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Adenocarcinoma of the Prostate peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Adenocarcinoma of the Prostate. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
3 profiles.
2017–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 109 selected PubMed records and 27 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Adenocarcinoma of the Prostate unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT01468532
PeptideScanner retained ClinicalTrials.gov record NCT01468532 at 2026-11-15T22:05:38.400Z. Its registry update date was 2021-03-25, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 25, 2021
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT03689699
PeptideScanner retained ClinicalTrials.gov record NCT03689699 at 2026-11-15T21:52:09.579Z. Its registry update date was 2026-10-15, and PeptideScanner's reviewed identity mapping was degarelix.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- October 15, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT01023061
PeptideScanner retained ClinicalTrials.gov record NCT01023061 at 2026-07-30T21:24:24.232Z. Its registry update date was 2017-06-06, and PeptideScanner's reviewed identity mapping was leuprolide.
- PeptideScanner change date
- August 13, 2026
- Cited source date
- June 6, 2017
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Degarelix · 2026-10-15
ClinicalTrials.gov record NCT03689699
Completed at the retained observation.
Open attributed record →Pasireotide · 2021-03-25
ClinicalTrials.gov record NCT01468532
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-06-06
ClinicalTrials.gov record NCT01023061
Completed at the retained observation.
Open attributed record →